Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.29 | 0.04 |